You just read:

The Cancer Immunotherapy Market Will Capture Major-Market Sales of Over $13 Billion In 2023 and Will be Dominated by Immune Checkpoint Inhibitors

News provided by

Decision Resources Group

Jun 04, 2015, 09:30 ET